The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...

Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.

In 2024, the percentage of U.S. employers covering weight-loss drugs has increased, with notable rises among larger employers ...

Old Town Med Spa is among those being accused of using false advertising and deceptive marketing practices to sell ...

European mega-caps trail US 'Magnificent Seven' amid lack of artificial intelligence gains, while also facing China's ...

European mega-caps trail US 'Magnificent 7' amid lack of AI gains, while also facing China’s slowdown and rising geopolitical ...

The only approved oral GLP-1 drug is Rybelsus, a pill for type 2 diabetes from Novo Nordisk, the same company that makes ...

Catalent is vulnerable to facility closures whether from natural disasters or manufacturing issues, and a warning letter from the FDA or other regulatory agency can result in manufacturing delays or ...

Merck reported that a new formulation of Keytruda appears to deliver similar blood levels of the drug when given as a shot as ...

The first prescription for the drug in China will reportedly be issued at a public hospital in Shanghai this week and will ...

Patients in China will be able to purchase the blockbuster weight-loss drug Wegovy for 1,400 yuan, or about $193, just a ...

Novo Nordisk's blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP on Tuesday ...